Sponsor or institution
Clinical trials and research at Vast Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $3.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Nebulized ALX1: a new inhaled antimicrobial for tough lung infections
A new inhaled medicine called ALX1 is being tested to help people with hard-to-treat non-tuberculous mycobacterial (NTM) lung infections by delivering nitric oxide directly into the lungs.
-
Inhaled nitric-oxide releasing prodrug to fight drug-resistant Klebsiella pneumoniae infections
A new inhaled medicine aims to deliver nitric oxide directly to the lungs to help treat tough, drug-resistant Klebsiella pneumoniae infections.
-
Nebulized NO-releasing therapy for Pseudomonas infections in bronchiectasis
A new inhaled nitric oxide–releasing treatment is being tested to help people with bronchiectasis who have lung infections from Pseudomonas bacteria.
-
Using a new treatment to fight lung infections caused by Pseudomonas aeruginosa in patients with bronchiectasis
This study is testing a new inhalable treatment for people with bronchiectasis who have tough lung infections caused by Pseudomonas aeruginosa, aiming to help them breathe better and reduce infections.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.